Advertisement

Life-Sciences-Europe.com
The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Novo to Acquire Altasciences from Audax Private Equity (2021-02-22)
Novo Holdings A/S today announced that it has agreed to acquire Altasciences from Audax Private Equity. Founded in 1992, Altasciences is a leading, fully-integrated, early drug development services platform, providing the pharma and biotech industries with a t... - Evox Therapeutics’ £69.2m Series C Led by Redmile Group (2021-02-18)
Financing round significantly oversubscribed by both new and existing investors Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome platform Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading... - Charles River Acquires Cognate BioServices for $875m in Cash (2021-02-17)
– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector – – Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution from Discovery through CGMP Manufactu... - Almirall: License to Sell Wynzora Cream in Europe from MC2 (2021-02-17)
> In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply > MC2 Therapeutics and Almirall partner to make Wynzora® Cream a leading topical ... - Cellectis & Cytovia to Develop iPSC-Derived NK Cells (2021-02-16)
Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Natural Killer (NK) and Chimeric Antigen Receptor (CAR)-NK cells derived from induced pluripotent stem cells (iPSCs), and Cellectis (Euronext Growth: ALCLS -Na... - Onward Tx Licenses Bispecific Ab Program from Biomunex (2021-02-16)
Onward Therapeutics will also invest in Biomunex, participating in the ongoing Series A funding round Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapy through the discovery and development of bi- and multi-specific... - Centessa Launches with $250m Series A & New RnD Model (2021-02-16)
> Merger of 10 Privately Held Biotech Companies with Highly Validated Programs Led by Industry Leading Teams to Operate Under Centessa Umbrella > Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Henderson I... - Immunocore Appoints Ralph Torbay as Head of Commercial (2021-02-16)
> Ralph Torbay appointed Head of Commercial to spearhead the launch of tebentafusp > Dr. Roy S. Herbst appointed as a Non-Executive Director to the Board Immunocore Holdings plc (Nasdaq: IMCR), (or the “Company” or “Immunocore”), a late-stage biotechnology ... - EW Group Acquires Hygiena from Warburg Pincus (2021-02-16)
EW GROUP, a German strategic holding company in the field of animal breeding, health, nutrition and diagnostics, announced today the acquisition of Hygiena, a leader in food safety and environmental testing solutions. The terms of the transaction have not been disc... - Cellink to Acquire Ginolis for €70m in Cash & Shares (2021-02-15)
CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of Ginolis Oy ("Ginolis"), a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries, to acquire all shares for a purc...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!
» Start here with the latest News!Advertisement
![Picture [iito] Plain Stupid Simple 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-plain-stupid-simple.jpg)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top